# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Swami Vivekananda (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI032-SYN
- Date: 2026-02-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anjali Thornbury-Mensah, MD
- Calendar frame: modern shifted

## What we are working on

- He is thirsty, up at night to pass urine, tired and losing weight, and wants to know whether he truly has diabetes and what kind **S**
- He wants any treatment to fit his monastic life: his diet, his fasts and his travel **S**
- He has never been able to fall asleep easily, and broken nights now leave him exhausted **S**

## Your goals

- Diabetes confirmed and classified within a week. Target: 2026-02-16. Recorded outcome: Type 2 diabetes confirmed by A1c 9.4 percent and fasting glucose 172 mg/dL; GAD65 antibodies negative and C-peptide preserved. **S**
- A1c below 7 percent without hypoglycemia, in a way that fits his diet and fasts. Target: 2026-10-27. Recorded outcome: A1c 6.9 percent on metformin; no hypoglycemia; fasts kept safely. **S**
- Blood pressure below 130/80. Target: 2026-03-23. Recorded outcome: Home 128/80 and clinic 128/80 two weeks after starting losartan. **S**
- Albuminuria reduced and kidney function preserved. Target: 2027-01-26. Recorded outcome: Urine albumin-to-creatinine ratio down from 46 to 34 mg/g; eGFR 103; empagliflozin started. **S**
- Falling asleep within 30 minutes on most nights. Target: 2026-12-08. Recorded outcome: About 45 minutes after four of six sessions. **S**

## What we agreed to do

- Endocrinology consultation in one week, the same day as fasting blood tests, to confirm and classify diabetes (A1c, fasting glucose, GAD antibodies, C-peptide), and advise on treatment that fits his diet, his religious fasts and his travel. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026) **S**
- Diagnostic tests in one week, fasting: A1c, fasting plasma glucose, GAD65 antibodies, C-peptide, urine albumin-to-creatinine ratio, lipid panel, ALT, TSH and vitamin B12; urine ketones negative today; drink water freely while thirsty and avoid waterless fasts until the results are known; return the same day if vomiting, abdominal pain or drowsiness. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026 (2026) **S**
- Home blood pressure readings twice daily for a week with a validated upper-arm cuff, because clinic readings are raised. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026) **S**
- Insomnia: sleep diary for two weeks, screening for sleep apnea, and cognitive behavioral therapy for insomnia adapted to his pre-dawn meditation; no sleeping tablets, by his preference; nocturia to be reviewed once glucose is treated. Guideline: Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021) **S**
- Metformin extended-release with the evening meal, titrated to 2000 mg, chosen by shared decision over early combination therapy or an injected GLP-1 receptor agonist; home glucose meter; diabetes education and medical nutrition therapy for a mostly vegetarian plan built on his monastery meals, his choices and his fasts; sulfonylureas avoided because of fasting. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026 (2026); Bhupathiraju SN, et al. A healthy plant-based diet is favorably associated with cardiometabolic risk factors among participants of South Asian ancestry. Am J Clin Nutr 2022;116(4):1078-1090 (PMID 35731596) (2022) **S**
- Religious fasting plan adapted from IDF-DAR risk stratification: fasts with fruit, milk and water allowed; waterless fasts only once glucose is steady, with hydration; metformin with the meal that ends the fast; glucose checks at midday and before breaking the fast; break the fast below 70 or above 300 mg/dL or when unwell. Guideline: 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026 (2026); Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021) **S**
- Vaccines for an adult with diabetes: influenza and COVID-19 each season, PCV20 once, hepatitis B (two doses) and Tdap. Guideline: Adult Immunization Schedule by Age (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026) **S**
- Hypertension with albuminuria: losartan 25 mg daily (an ARB rather than an ACE inhibitor, to avoid cough), less salt, home readings, potassium and creatinine two weeks after starting. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026) **S**
- Cardiovascular prevention: atorvastatin 10 mg daily at 35 with diabetes, South Asian ancestry, albuminuria and hypertension, by his choice; lipid panel six to twelve weeks after starting. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344) (2013) **S**
- Travel plan for months away: medicine and test-strip supply, sick-day rules (hold metformin and losartan when vomiting, with diarrhea or unable to drink), monthly messages with readings, and A1c, urine albumin and lipids at three months wherever he is. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026) **S**
- Asthma attack in a man with diabetes: prednisone 40 mg for five days with glucose checks before breakfast and the evening meal and a call for readings above 300 mg/dL; as-needed budesonide-formoterol until spirometry; review within a week. Guideline: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025) **S**
- Diabetic kidney disease G1 A2: empagliflozin 10 mg each morning, skipped on waterless fast days and stopped with metformin when unable to eat or drink; losartan continued; potassium, creatinine and urine albumin in three months, then every six months. Guideline: 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021) **S**
- Asthma on GINA track 1, step 3: budesonide-formoterol one inhalation twice daily and as needed with a spacer, a written action plan, a smoke-free room, review in four to six weeks and spirometry in three months. Guideline: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) **S**

## Follow-up

- 2026-02-09: New patient visit for thirst, frequent urination, tiredness and weight loss in a 35-year-old monk told of diabetes a year ago and never tested: examination, random glucose and urine tests, and planning of fasting tests to confirm and classify diabetes; long-standing insomnia; raised blood pressure **S**
- 2026-02-16: Diagnosis visit with the endocrinology consultation: A1c, fasting glucose, GAD antibodies, C-peptide, urine albumin, lipids and B12; type 2 diabetes confirmed; metformin by shared decision; nutrition and fasting plans **S**
- 2026-03-09: Periodic preventive visit **S**
- 2026-03-23: Five-week diabetes review before a long journey: glucose log, metformin dose, kidney function and potassium on losartan, repeat urine albumin, retinal photographs, statin, and a travel and fasting plan **S**
- 2026-10-27: Review after seven months away and a week after an asthma attack: A1c, kidneys, lipids, spirometry with bronchodilator response and FeNO; asthma and diabetic kidney disease confirmed; empagliflozin and maintenance-and-reliever inhaler; fasting plan for the coming festival **S**

This teaching document does not replace care from a qualified clinician.
